Erişkinde aşılama

Aşılama ile hastalıkların azalması, 20. yüzyılın en önemli medikal başarılarından biridir. Aşılama ile çiçek hastalığı global olarak eradike edilmiş olup, poliomiyelit, kızamık ve difteri gibi çok sayıda hastalık bir çok ülkede nadiren görülür hale gelmiştir. Günümüzde aşı ile korunulabilen hastalıkların morbidite ve mortalitesi sadece çocuklarda değil erişkinlerde de önemsenmektedir. Erişkinlerin aşılanması birçok ciddi hastalıktan koruyabilmektedir. Her yıl yaklaşık 30-50 bin erişkin aşı ile önlenebilir hastalıklardan yaşamını yitirmektedir. Erişkinlerde bu hastalıkların başında influenza ve pnömokokal hastalıklar gelmektedir.Bu güncel derlemede erişkinde aşılama anlatılmaktadır.

Anahtar Kelimeler:

Aşılar, Viral hepatit aşıları, Viral aşılar, Aşılar, cansız, Hepatit B aşıları, Pnömokok aşıları, Hepatit A aşıları, Difteri-tetanos aşısı, Bağışıklama, Bakteriyel aşılar, Erişkin, Grip aşıları, Risk faktörleri

Adult immunization

The reduction of disease through immunization is one of the greatest medical successes of the 20th century. Smallpox has been globally eradicated, and devastating diseases such as poliomyelitis, measles and diphtheria are now exceedingly rare in many countries. Currently, the overwhelming morbidity and mortality from vaccine-preventable disease occurs not only in children, but also in adults. Providing immunizations for adults can prevent serious diseases. Each year, an estimated 30,000-50,000 adults die from vaccine-preventable diseases. Most of the mortality in adults is attributable to two diseases: influenza and pneumococcal disease. In the current article, adult immunization is explained.

Keywords:

Vaccines, Viral Hepatitis Vaccines, Viral Vaccines, Vaccines, Inactivated, Hepatitis B Vaccines, Pneumococcal Vaccines, Hepatitis A Vaccines, Diphtheria-Tetanus Vaccine, Immunization, Bacterial Vaccines, Adult, Influenza Vaccines, Risk Factors,

PDF

___

1. American College of Physicians Task Force on Adult Immunization/ Infectious Diseases Society ofAmerica: Guide for adult immunization, 3rd ed, American College of Physicians, Philadelphia (1994).
2. Butler J, Breiman R, Campbell J, Lipman HB, Broome CV, Facklam RR: Pneumococcal polysaccharide vaccine efficacy:An evaluation of current recommendations, JAMA 1993;270(15):1826-31.
3. CarmanWF, ElderAG,Wallace LAet al: Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial, Lancet 2000;355(9198):93-7.
4. Centers for Disease Control and Prevention:Update on adult immunization: recommendations of the Immunization Practices Advisory Committee (ACIP), MMWR 1991;40(RR-12):1-94.
5. Centers for Disease Control and Prevention: Prevention and control of influenza: recommendations of the Immunization PracticesAdvisory Committee (ACIP), MMWR 1995;44(RR-3):1-22.
6. Centers for Disease Control and Prevention: Prevention of varicella: recommendations of theAdvisory Committee on Immunization Practices (ACIP), MMWR 1996;45(No. RR-11):1-25.
7. Centers for Disease Control and Prevention: Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control ofmumps: recommendations of theAdvisory Committee on Immunization Practices (ACIP), MMWR 1998;47(No. RR-8):1-57.
8. Centers for Disease Control and Prevention: Prevention of varicella: updated recommendations of theAdvisory Committee on Immunization Practices (ACIP), MMWR 1999;48(No. RR-6):1-5.
9. Centers for Disease Control and Prevention:RubellaOutbreak -Westchester County, New York, 1997-1998, MMWR 1999;48(26):560-3.
10. Centers for Disease Control and Prevention: Prevention and control ofmeningococcal disease: recommendations of theAdvisory Committee on Immunization Practices (ACIP), MMWR 2000;49(No. RR-7):1-10.
11. Centers for Disease Control and Prevention: Notice to readers: Revised ACIP recommendation for avoiding pregnancy after receiving a rubellacontaining vaccine, MMWR 2001;50(49):1117.
12. Centers for Disease Control and Prevention: Recommended adult immunization schedule-United States, 2002-2003,MMWR2002;51:904- 8.Available at: http://www.cdcgov/nip/recs/adult-schedule.pdf.Accessed February 19, 2003.
13. CDC: Recommended adult immunization schedule-United States,October 2006-September 2007, MMWR 2006;55(40).
14. Fedson D:Adult immunization: summary of the NationalVaccineAdvisory Committee report, JAMA 1994;272(14):1133-7.
15. Gardner P, SchaffnerW: Immunization of adults, N Engl J Med 1993; 328(17):1252-8.
16. Honkanen PO,KeistinenT,Kivela SL: Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly, Arch Intern Med 1996;156(2):205-8.
17. Immunization PracticesAdvisory Committee:Assessing adult vaccination status at age 50 years, MMWR 1995;44:561-3.
18. Jackson LA, Neuzil KM, Yu O et al: Effectiveness of pneumococcal polysaccharide vaccine in older adults, N Engl J Med 2003;348(18): 1747-55.
19. Köksal İ: Hepatit B aşıları, “Usluer G, Leblebicioğlu H, Ünal S (eds): 133-148, Bilimsel Tıp Yayınevi, 2005.
20. Köksal İ: Tetanoz, Türkiye Klinikleri: Enfeksiyon 2006;2(28):113-8.
21. Mac Kenzie WR, Davis JP, Peterson DE, HibbardAJ, Becker G, Zarvan BS:Multiple false-positive serologic tests forHIV, HTLV-1, and hepatitis C following influenza vaccination, 1991, JAMA 1992;268(8):1015-7.
22. Neuzil KM, Danar D:Adult immunizations:Areview of current recommendations from Medscape Family Medicine/Primary Care, Feb 2003.
23. Prevention and Control of Influenza: Recommendations of theAdvisory Committee on Immunization Practices (ACIP),MMWR2004;53 (RR06): 1.
24. Potter J, Stott DJ, Roberts MA et al: Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients, J Infect Dis 1997;175(1):1-6.
25. Recommended Adult Immunization Schedule - United States, 2003- 2004, MMWR 2003;52:965.
26. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM: Meningococcal disease, N Engl J Med 2001;344(18):1378-88.
27. Sağsöz N,Apan T: Gebelerde tetanoz, hepatit B ve rubella seropozitiflik oranları, Türkiye Klinikleri: Jinekoloji-Obstetrik 2002;12(1):52-5.
28. Seward JF, Watson BM, Peterson CL et al: Varicella disease after introduction of varicella vaccine in the United States, 1995-2000, JAMA 2002;287(5):606-11.
29. SibleyWA, Bamford CR, Laguna JF: Influenza vaccination in patients with multiple sclerosis, JAMA 1976;236(17):1965-6.
30. Tuncer-Ertem G, Sakarya S,Aydın N, Cenan N:Yaşlı insanlarda tetanoz bağışıklığının araştırılması, İnfeksiyon Derg 2004;18(1):35-8.